Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London

BACKGROUND: Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Gayan, Khondoker, Mizanur, Broadbent, Matthew, Breen, Gerome, Stewart, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239015/
https://www.ncbi.nlm.nih.gov/pubmed/25411838
http://dx.doi.org/10.1371/journal.pone.0109484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239015/
https://www.ncbi.nlm.nih.gov/pubmed/25411838
http://dx.doi.org/10.1371/journal.pone.0109484

Ejemplares similares